參考文獻 |
第五章 參考文獻
李世瑛. 2001. Thioredoxin Peroxidase II蛋白與亞砷酸鈉毒性與結合作用之研究. 國立中央大學碩士論文.
Aposhian, H. V. (1989)Biochemical toxicology of arsenic. Rev. Biochem. Toxicol. 10: 265-299.
Applegate, L. A., P. Lushcher, and R. M. Tyrrell (1991) Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. Cancer Res. 51: 974-978.
Berolero, F., G. Pozzi, E. Sabbioni, and U. Saffiotti (1987) Cellular uptake and metabolic reduction of pentavalent to trivalent arsenic as determinants of cytotoxicity and morphological transformation. Carcinogenesis 8: 803-808.
Bogdan, G. M., A. Sampayo-Reyes, and H. V. Aposhian (1994) Arsenic binding proteins of mammalian systems: I. Isolation of three arsenite-binding proteins of rabbit liver. Toxicology 93: 175-193.
Buchet, J. P., and R. Lauwerys (1985) Study of inorganic arsenic methylation by rat liver in vitro: relevance for the interpretation of observation in man. Arch. Toxicol. 57: 125-129.
Carlson-Lynch, H., B. D. Beck, and P. D. Boardman (1994) Arsenic risk assessment.Environ. Health Perspect. 102: 354-356.
Chae, H. Z., H. J. Kim, S. W. Kang, and S. G. Rhee (1999) Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes. Res. Clin. Pract. 45: 101-112.
Chae, H. Z., I. H. Kim, K. Kim, and S. G. Rhee (1993) Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae. J. Biol. Chem. 268: 16815-16821.
Chae, H. Z., S. J. Kim, S. W. Chung, and S. G. Rhee (1994) Thioredoxin-dependent peroxide reductase from yeast. J. Biol. Chem. 269: 27670-27678.
Chae, H. Z., K. Robison, L. B. Poole, G. Church, and S. G. Rhee (1994) Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. Proc. Natl. Acad. U.S.A. 91: 7017-7021.
Chen, C. J., Y. C. Chuang, T. M. Lin, and H. Y. Wu (1985) Malignant neoplasms among residents of a blackfoot diease-endemic area in Taiwan: hight-arsenic artesian well water and cancers. Cancer Res. 45: 5895-5899.
Chen, C. J., Y. M. Hsueh, M. S. Lai, M. P. Shyu, S. Y. Chen, M. M. Wu, T. L. Kuo, and T. Y. Tai (1995) Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 25: 53-60.
Chen, G. Q., J. Zhu, X. G. Shi, J. H. Ni, H. J. Zhong, G. Y. Si, X. L. Jin, W. Tang, X. S. Li, S. M. xong, Z. X. Shen, G. L. Sun, J. Ma, P. Zhang, T. D. Zhang, C. Gazin, T. Naoe, S. J. Chen, Z. Y. Wang, and Z. Chen (1996) In virto studies on cellular and molecular mechanisms of arsenic trioxide(As2O3) in the treatment of acute promyelocytic leukemia:As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood 88: 1052-1061.
Chen, H. Z., I. H. Kim, K. Kim, and S. G. Rhee (1993) Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae. J. Biol. Chem. 268: 16815-16821.
Chen, M. L., R. S. King, and H. J. Armbrecht (1990) Sodium-dependent phosphate transport in primary cultures of renal tubule cells from young and adult rats. J. Cell. Physiol. 143: 488-493.
Crecelius, E. A. (1977) Changes in the chemical speciation of arsenic following ingestion by man. Environ. Health Perspect. 19: 147-150.
Del Razo, L. M., M. A. Arellano, and M. E. Cebrian (1990) The oxidation states of arsenic in well-water from a chronic arsenicism of Northern Mexico. Environ. Pollut. 64: 143-153.
Fan, S. R., I. C. Ho, F. L. Yeoh, C. J. Lin, and T. C. Lee (1996) Squalene inhibits sodium arsenite-induced sister chromatid exchanges and micronuclei in Chinese hamster ovary-K1 cells. Mutat. Res. 368: 165-169.
Fischer, A. B., J. P. Buchet, and R. Lauwerys (1985) Arsenic uptake, cytotoxicity and detoxification studied in mammalian cells in culture. Arch. Toxicol. 57: 168-172.
Gorbsky, G. J. (1994) Arsenic in human medicine, arsenic in the environment. Part2: Human health and ecosystem effects, New York.
Gurley, L. R., R. A. Walters, J. H. Jett, and R. A. Tobey (1980) Response of CHO cell proliferation and histone phosphorylation to sodium arsenite. J. Toxicol. Environ. Health. 6: 87-105.
Huang, R. N., and T. C. Lee (1996) Cellular uptake of trivalent arsenite and pentavalent arsenate in KB cells cultured in phosphate-free medium. Toxicol. Appl. Pharmacol. 136: 243-249.
IARC. (1980) Carcinogenesis of arsenic and arsenic compounds. IARC. 23: 37-141.
Ishii, T., M. Yamada, H. Sato, M. Matsue, S. Taketani, K. Nakayama, Y. Sugita, and S. Bannai (1993) Cloning and characterization of a 23-kDa stress-induced mouse peritoneal macrophage protein. J. Biol. Chem. 268: 18633-18636.
Ishinishi, N., A. Yamamoto, A. Hisanaga, and T. Inamasu (1983) Tumorigenicity of arsenic trioxide to the lung in syrian golden hamsters by intermittent instillations. Cancer Lett. 21: 141-147.
Ivhimiya, S., J. G. Davis, D. M. O'rourke, M. Katsumata, and M. I. Greene (1997) Murine Thioredoxin peroxidase delays neuronal apoptosis and is expressed in areas of the brain most susceptible to hypoxic and ischemic injury. DNA Cell Biol. 16: 311-321.
Iwahara, S., H. Satoh, D. X. Song, J. Webb, A. L. Burlingame, Y. Nagae, and U. Muller-Eberhard (1995) Purification, characterization, and cloning of a heme-binding protein (23 kDa) in rat liver cytosol. Biochemistry 34: 13398-13406.
Jin, D. Y., H. Z. Chae, S. G. Rhee, and K. T. Jeang (1997) Regulatory role for a novel human thioredoxin peroxidase in NF-kB Activation. J. Biol. Chem. 272: 30952-30961.
Kang, S. W., I. C. Baines, and S. G. Rhee (1998) Characterization of a mammalian peroxiredoxin that contains one conserved cysteine. J. Biol. Chem. 273: 6303-6311.
Kang, S. W., H. Z. Chae, M. S. Seo, K. Kim, and I. C. Baines (1998) Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-a. J. Biol. Chem. 273: 6297-6302.
Kawai, S., S. Takeshita, M. Okazaki, R. Kikuno, A. Kudo, and E. Amann (1994) Cloning and characterization of OSF-3, a new member of the MER5 family, expressed in mouse osteoblastic cells. J. Biochem. 115: 641-643.
Knowles, F. C., and A. A. Benson (1983) The biochemistry of arsenic. Trends Biochem. Sci. 8: 178-180.
Lee, T. C., and I. C. Ho (1995) Modulation of cellular antioxidant defense activities by sodium arsenite in human fibroblasts. Arch. Toxicol. 69: 498-504.
Lee, T. C., M. Oshimura, and J. C. Barrett (1985) Comparison of arsenic-induced cell transformation, cytotoxicity, mutation and cytogenetic effects in syrian hamster embryo cells in culture. Carcinogenesis 6: 1421-1426.
Lee, T. H., S. L. Yu, S. U. Kim, Y. M. Kim, I. Choi, S. W. Kang, S. G. Rhee, and D. Y. Yu (1999) Characterization of the murine gene encoding 1-Cys peroxiredoxin and identification of highly homologous genes. Gene 234: 337-344.
Lee, T. H., S. L. Yu, S. U. Kim, K. K. Lee, S. G. Rhee, and D. Y. Yu (1999) Characterization of mouse peroxiredoxin I genomic DNA and its expression. Gene 239: 243-250.
Lee, S. P., Hwang, Y. S., Y. J. Kim, Kwon, K. S.,H. J. Kim, K. Kim, and Chae, H. Z. (2001) Cyclophilin A binds to peroxiredoxins and activates its peroxidase activity. J. Biol. Chem. 276: 29826-29832.
Li. B., Ishii. T., Tan. C. P., Soh. J. W., and Stephen. S. P. (2002) Pathway of induction of peroxiredoxin I expression in osteoblasts. J. Biol. Chem. 277: 12418-12422.
Li, W., and I. N. Chou (1992) Effects of sodium arsenite on the cytoskeleton and cellular glutathione levels in cultured cells. Toxicol. Appl. Pharmacol. 114: 132-139.
Lim, Y. S., M. K. Cha, C. H. Yun, H. K. Kim, K. Kim, and I. H. Kim (1994) Purification and characterization of thiol-specific antioxidant protein from human red blood cell: A new type of antioxidant protein. Biochem. Biophysiol. Res. Commun. 199: 199-206.
Liu, Y. C., and H. Huang (1997) Involvement of calcium-dependent protein kinase C in arsenite-induced genotoxicity in Chinese hamster ovary cells. J. Cell Biochem. 64: 423-433.
Lynn, S., J. N. Shiung, J. R. Gurr, and K. Y. Jan (1998) Arsenite stimulates poly(ADP-ribosylation) by generation of nitric oxide. Free Radic. Biol. Med. 24: 442-449.
Mann, S., P. O. Droz, and M. Vahter (1996) Physiologically based pharmacokinetic model for arsenic exposure. II. Validation and application in humans. Toxicol. Appl. Pharmacol. 140: 471-486.
Mizusawa, H., T. Ishii, and S. Bannai (2000) Perosiredoxin I (macrophage 23 kDa stress protein ) is highly and widely expression in the rat nervous system. Neurosci. Lett. 283: 57-60.
Morton, W. E., and D. A. Dunnette (1994) Health effect of environmental arsenic. In Arsenic in the environment, New York.
Nishizuka, Y. (1984) The molecular heterogeneity of protein kinase C and implications for cellular regulation. Nature(London) 334: 661-665.
Nishizuka, Y. (1995) Proteinkinase C and lipid signaling for sustained cellular responses. FASEB J. 9: 484-496.
Prosperi, M. T., D. Ferbus, I. Karczinski, and G. Goubin (1993) A human cDNA corresponding to a gene overexpressed during cell proliferation encodes a product sharing homology with amoebic and bacterial proteins. J. Biol. Chem. 268: 11050-11056.
Prosperi, M. T., D. Ferbus, D. Rouillard, and G. Goubin (1998) The pag gene product, a physiological inhibitor of c-abl tyrosine kinase, is overexpressed in cells entering S phase and by contact with agents inducing oxidative stress. FEBS Lett. 423: 39-44.
Schroder, E., J. A. Littlechild, A. A. Lebedev, N. Errington, A. A. Vagin, and M. N. Isupov (2000) Crystal structure of decameric 2-Cys peroxiredoxin from human erythrocytes at 1.7Å resolution. Structure 8: 605-615.
Scott, N., K. M. Hatlelid, N. E. MacKenzie, and D. E. Carter (1993) Reaction of arsenic(III) and arsenic(V) species with glutathione. Chem. Res. Toxicol. 6: 102-106.
Shau, H., L. H. Butterfield, R. Chiu, and A. Kim (1994) Cloning and sequencing analysis of candidate human natural killer-enhancing factor genes. Immunogenetics 40: 129-134.
Shau, H., A. C. J. Huang, M. Faris, and R. Nazarian (1998) Thioredoxin peroxidase (Natural killer Enhancing factor) regulation of activator protein-1 function in endothelial cells. Biochem. Biophysiol. Res. Commun. 249: 683-686.
Sheehy, J. W., and J. H. Jones (1993) Assessment of arsenic exposures and controls in gallium arsenide production. Am. Ind. Hyg. Assoc. J. 54: 61-69.
Styblo, M., and D. J. Thomas (1997) Binding of arsenicals to proteins in an in vitro methylation system. Toxicol. Appl. Pharmacol. 147: 1-8.
Sunderman, F. W. (1979) Mechanism of metal carcinogens. Biol. Trace. Elem. Res. 1: 53-86.
Tseng, C. H., C. K. Chong, C. J. Chen, and T. Y. Tai (1996) Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Atherosclerosis 120: 125-133.
Tseng, W. P. (1977) Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic.Environ. Health. Perspect. 19: 109-119.
Tseng, W. P., H. M. Chu, S. W. How, J. M. Fong, C. S. Lin, and S. Yeh (1968) Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. 40: 453-463.
Vahter, M., and J. Envall (1983) In vivo reduction of arsenate in mice and rabbits. Environ. Res. 32: 14-24.
Wang, T. S., C. F. Kuo, K. Y. Jan, and H. Huang (1996) Arsenite induces apoptosis in Chinese hamster ovary cells by generation of reactive oxygen species. J. Cell. Physiol. 169: 256-268.
Wang, T. S., Y. F. Shu., Y.C. Liu., K.Y. Jan, and H. Huang (1997) Glutathione peroxidase and catalase modulate the genotoxicity of arsenite. Toxicity.121: 229-237.
Watabe, S., H. Kohno, H. Kouyama, T. Hiroi, N. Yago, and T. Nakazawa (1994) Purification and characterization of a substrate protein for mitochondrial ATP-dependent protease in bovine adrenal cortex. J. Biochem. 115: 648-654.
Wen, S. T., and R. A. Van Etten (1997) The pag gene product, a stress-induced protein with antioxidant properties, is an Abl SH-3 binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Genes Dev. 11: 2456-2467.
Wen, W. N., T. L. Lieu, H. J. Chang, S. W. Wuu, M. L. Yau, and K. Y. Jan (1981) Baseline and sodium arsenite-induced sister chromatid exchange in cultured lympocytes from patients with Blackfoot disease and healthy persons. Hum. Genet. 59: 201-203.
Yamamoto, T., Y. Matsui, S. Natori, and M. Obinata (1989) Cloning of a housekeeping-type gene (MER5) preferentially expressed in murine erythroleukemia cells. Gene 80: 337-343.
Yamanaka, K., A. Hasegawa, R. Sawamura, and S. Okada (1991) Cellular response to oxidative damage in lung induced by the administration of dimethylarsenic acid, a major metabolite of inorganic arsenics, in mice. Toxicol. Appl. Pharmacol. 108: 205-213.
Yanagawa, T., T. Ishikawa, T. Ishii, K. Tabuchi, S. Iwasa, S. Bannai, K. Omura, H. Suzuki, and H. Yoshida (1999) Peroxiredoxin I expression in human thyroid tumors. Cancer Lett. 145: 127-132.
Yih, L. H., and T. C. Lee (1999) Effects of exposure protocols on induction of kinetochore-plus and -minus micronuclei by arsenite in diploid human fibroblasts. Mutat. Res. 440: 75-82.
Zhang, P., B. Liu, S. W. Kang, M. S. Seo, S. G. Rhee, and L. M. Obeid (1997) Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2. J. Biol. Chem. 272: 30615-30618. |